Gyre Therapeutics (GYRE) Asset Utilization Ratio (2011 - 2026)

Gyre Therapeutics (GYRE) has 15 years of Asset Utilization Ratio data on file, last reported at 0.71 in Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.71, down 9.55% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.71 (down 9.55% YoY), and the FY2025 annual result was 0.8, down 8.51% from the prior year.
• Asset Utilization Ratio held at 0.71 in Q1 2026 per GYRE's latest filing, from 0.72 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 16.8 in Q3 2023 and troughed at 0.06 in Q3 2022.
• A 5-year average of 2.37 and a median of 0.84 in 2024 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio jumped 29610.75% in 2023, then plunged 94.92% in 2024.
• A 5-year view of Asset Utilization Ratio shows it stood at 1.77 in 2022, then rose by 1.5% to 1.79 in 2023, then slumped by 52.95% to 0.84 in 2024, then decreased by 15.11% to 0.72 in 2025, then dropped by 0.41% to 0.71 in 2026.
• Business Quant data shows GYRE's Asset Utilization Ratio at 0.71 in Q1 2026, 0.72 in Q4 2025, and 0.69 in Q3 2025.